Progression to Psoriatic Arthritis Among Psoriasis Patients Treated With JAK Inhibitors Compared With IL-17/23 Inhibitors
Journal of Drugs in Dermatology · 01.11.2026 · 25 (11) · 997-1002
DOI: 10.36849/jdd.9963 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.10.2026. Verfasst von Robert Adler und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Interleukin-17, Interleukin-23, Janus Kinase Inhibitors.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Adler, R., Kozlov, M., Sash, S., Mehta, M. D., Cowen, E., Svigos, K., & Feig, J. L. (2026). Progression to Psoriatic Arthritis Among Psoriasis Patients Treated With JAK Inhibitors Compared With IL-17/23 Inhibitors. Journal of Drugs in Dermatology, 25(11), 997-1002. https://doi.org/10.36849/jdd.9963
Vancouver
Adler R, Kozlov M, Sash S, Mehta MD, Cowen E, Svigos K, et al. Progression to Psoriatic Arthritis Among Psoriasis Patients Treated With JAK Inhibitors Compared With IL-17/23 Inhibitors. Journal of Drugs in Dermatology. 2026;25(11):997-1002. doi:10.36849/jdd.9963
BibTeX
@article{Adler2026,
author = {Adler, Robert and Kozlov, Michael and Sash, Sara and Mehta, Manan D and Cowen, Emily and Svigos, Katerina and Feig, Jessica Lori},
title = {Progression to Psoriatic Arthritis Among Psoriasis Patients Treated With JAK Inhibitors Compared With IL-17/23 Inhibitors},
journal = {Journal of Drugs in Dermatology},
year = {2026},
volume = {25},
number = {11},
pages = {997--1002},
doi = {10.36849/jdd.9963}
}
EUVIMED